7 employees
Swiss Nuclides is a developer of a novel radionuclide PET tracers for the precision diagnostics.
2017
$2.9M
from 1 investors over 1 rounds
Swiss Nuclides raised $2.9M on August 2, 2021
Investors: Turos Capital AG